OMERS Administration Corp’s Aratana Therapeutics, Inc. PETX Stock Holding History

OMERS Administration Corp’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-997,016	Closed	-$5.21M	–	511
2019 Q2	$5.21M	Buy	+997,016	New	+$4.48M	0.05%	199

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

OMERS Administration Corp's PETX Position: Q3 2019 in Review

OMERS Administration Corp sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 997,016 shares — an estimated $5.21M sold.

OMERS Administration Corp first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $5.21M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

OMERS Administration Corp reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
OMERS Administration Corp sold 997,016 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $5.21M.
OMERS Administration Corp first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
OMERS Administration Corp's Aratana Therapeutics, Inc. position peaked at $5.21M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on OMERS Administration Corp's 13F filing for Q3 2019, filed 12 Nov 2019.